ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.04
0.60%
US Tech 100
17,445.60
2.16%
S&P 500
5,127.79
1.26%
US Dollar vs CAD
1.36715
0.03%
Bitcoin
63,223.47
6.94%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Biolase Inc (BIOL)

  7. Biolase Inc (BIOL) News

BIOL Biolase Inc

0.1499
0.0015 (1.01%)
After Hours
Last Updated: 18:09:29
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Biolase Inc BIOL NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.0015 1.01% 0.1499 18:09:29
Open Price Low Price High Price Close Price Previous Close
0.1488 0.1421 0.1498 0.1451 0.1484
more quote information »

Recent News

Date Time Source Heading
3/08/202405:31EDGAR2Form PRE 14A - Other preliminary proxy statements
3/05/202405:05EDGAR2Form 8-K - Current report
2/27/202415:14EDGAR2Form 8-K - Current report
2/23/202415:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/21/202415:39EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/21/202406:01EDGAR2Form 8-K - Current report
2/15/202416:15EDGAR2Form 8-K - Current report
2/14/202412:10EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/13/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
2/13/202419:03EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/09/202407:44EDGAR2Form S-1/A - General form for registration of securities..
2/07/202405:11EDGAR2Form S-1/A - General form for registration of securities..
2/07/202405:04EDGAR2Form 8-K - Current report
1/30/202420:57EDGAR2Form S-1/A - General form for registration of securities..
1/29/202416:01EDGAR2Form 8-K - Current report
1/29/202405:30PRNUSBIOLASE REPORTS UNAUDITED REVENUE GROWTH FOR FULL YEAR 2023..
1/24/202416:21EDGAR2Form S-8 - Securities to be offered to employees in employee..
1/19/202405:09EDGAR2Form S-1 - General form for registration of securities under..
1/08/202415:05PRNUSBIOLASE ENHANCES EDUCATION OFFERINGS IN 2024 DUE TO..
1/03/202415:05PRNUSBIOLASE RECEIVES SECOND TOP WORKPLACES 2023 AWARD
12/29/202315:05EDGAR2Form 8-K - Current report
12/26/202316:22EDGAR2Form S-1 - General form for registration of securities under..
12/14/202315:05PRNUSBIOLASE RECEIVES TOP WORKPLACES 2023 AWARD
12/12/202315:05PRNUSBIOLASE Successfully Concludes Waterlase iPlus All Tissue..
12/08/202308:25EDGAR2Form 8-K - Current report
12/08/202308:23EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
12/06/202312:46PRNUSBIOLASE, Inc. Announces Pricing of $1.4 Million Registered..
11/17/202315:17EDGAR2Form 8-K - Current report
11/09/202315:52EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/202315:20EDGAR2Form 8-K - Current report
11/09/202315:05PRNUSBIOLASE REPORTS THIRD QUARTER FINANCIAL RESULTS; COMPANY..
11/08/202305:30PRNUSLandmark Study Performed by the Independent McGuire..
11/07/202315:05PRNUSBIOLASE TO REPORT THIRD QUARTER 2023 RESULTS ON NOVEMBER 9,..
10/18/202307:00PRNUSSWK Holdings Highlights Recent Achievements and Provides..
10/10/202314:53EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
9/18/202315:59EDGAR2Form 8-K - Current report
9/18/202315:30PRNUSBIOLASE Inc. Announces Closing of $4.5 Million Underwritten..
9/15/202316:27EDGAR2Form 424B1 - Prospectus [Rule 424(b)(1)]
9/15/202316:27EDGAR2Form 424B1 - Prospectus [Rule 424(b)(1)]
9/14/202308:08EDGAR2Form POS EX - Post-effective amendment adding exhibits to..
9/13/202322:16PRNUSBIOLASE Inc. Announces Pricing of $4.5 Million Underwritten..
9/13/202320:25EDGAR2Form S-1MEF - Registration adding securities to prior Form..
9/12/202314:26EDGAR2Form SC 13G - Statement of acquisition of beneficial..
9/11/202316:09EDGAR2Form S-1/A - General form for registration of securities..
8/30/202316:31EDGAR2Form S-1/A - General form for registration of securities..
8/10/202315:53EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/202315:07EDGAR2Form 8-K - Current report
8/10/202315:05PRNUSBIOLASE REPORTS RECORD CONSUMABLE SALES AS TOTAL SECOND..
8/02/202315:05PRNUSBIOLASE TO REPORT SECOND QUARTER 2023 RESULTS ON AUGUST 10,..
7/26/202315:38EDGAR2Form 8-K - Current report

Your Recent History

NASDAQ
BIOL
Biolase
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved